ZBTB7 Overexpression Contributes to Malignancy in Breast Cancer

REFERENCES

• Pessler, F.; Pendergrast, P.S.; Hernandez, N. Purification and characterization of FBI-1, a cellular factor that binds to the human immunodeficiency virus type 1 inducer of short transcripts. Mol Cell Biol 1997, 17(7), 3786–3798.
   PubMed Web of Science ®Google Scholar
• Kukita, A.; Kukita, T.; Ouchida, M.; Maeda, H.; Yatsuki, H.; Kohashi, O. Osteoclast-derived zinc finger (OCZF) protein with POZ domain, a possible transcriptional repressor, is involved in osteoclastogenesis. Blood 1999, 94(6), 1987–1997.
   PubMed Web of Science ®Google Scholar
• Davies, J.M.; Hawe, N.; Kabarowski, J.; Huang, Q.H.; Zhu, J.; Brand, N.J.; Leprince, D.; Dhordain, P.; Cook, M.; Morriss-Kay, G.; Zelent, A. Novel BTB/POZ domain zinc-finger protein, LRF, is a potential target of the LAZ-3/BCL-6 oncogene. Oncogene 1999, 18(2), 365–375.
   PubMed Web of Science ®Google Scholar
• Maeda, T.; Hobbs, R.M.; Merghoub, T.; Guernah, I.; Zelent, A.; Cordon-Cardo, C.; Teruya-Feldstein, J.; Pandolfi, P.P. Role of the proto-oncogene Pokemon in cellular transformation and ARF repression. Nature 2005, 433(7023), 278–285.
   PubMed Web of Science ®Google Scholar
• Huynh, K.D.; Fischle, W.; Verdin, E.; Bardwell, V.J. BCoR, a novel corepressor involved in BCL-6 repression. Gene Dev 2000, 14(14), 1810–1823.
   Google Scholar
• Wong, C.W.; Privalsky, M.L. Components of the SMRT corepressor complex exhibit distinctive interactions with the POZ domain oncoproteins PLZF, PLZF-RARalpha, and BCL-6. J Biol Chem 1998, 273(42), 27695–27702.
   PubMed Web of Science ®Google Scholar
• David, G.; Alland, L.; Hong, S.H.; Wong, C.W.; DePinho, R.A.; Dejean, A. Histone deacetylase associated with mSin3A mediates repression by the acute promyelocytic leukemia-associated PLZF protein. Oncogene 1998, 16(19), 2549–2556.
   PubMed Web of Science ®Google Scholar
• Dhordain, P.; Lin, R.J.; Quief, S.; Lantoine, D.; Kerckaert, J.P.; Evans, R.M.; Albagli, O. The LAZ3(BCL-6) oncoprotein recruits a SMRT/mSIN3A/histone deacetylase containing complex to mediate transcriptional repression. Nucleic Acids Res 1998, 26(20), 4645–4651.
   PubMed Web of Science ®Google Scholar
• Molnar, A.; Georgopoulos, K. The Ikaros gene encodes a family of functionally diverse zinc finger DNA-binding proteins. Mol Cell Biol 1994, 14(12), 8292–8303.
   PubMed Web of Science ®Google Scholar
• Sun, L.; Liu, A.; Georgopoulos, K. Zinc finger-mediated protein interactions modulate Ikaros activity, a molecular control of lymphocyte development. EMBO J 1996, 15(19), 5358–5369.
   PubMed Web of Science ®Google Scholar
• Schubot, F.D.; Tropea, J.E.; Waugh, D.S. Structure of the POZ domain of human LRF, a master regulator of oncogenesis. Biochem Biophys Res Commun 2006, 351(1), 1–6.
   PubMed Web of Science ®Google Scholar
• Livak, K.J.; Schmittgen, T.D. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods 2001, 25(4), 402–408.
   PubMed Web of Science ®Google Scholar
• Hiyama, K.; Kodaira, M.; Satoh, C. Detection of deletions, insertions and single nucleotide substitutions in cloned beta-globin genes and new polymorphic nucleotide substitutions in beta-globin genes in a Japanese population using ribonuclease cleavage at mismatches in RNA:DNA duplexes. Mutat Res 1990, 231(2), 219–231.
   PubMed Web of Science ®Google Scholar
• Zhao, Z.H.; Wang, S.F.; Yu, L.; Wang, J.; Chang, H.; Yan, W.L.; Fu, K.; Zhang, J. Expression of transcription factor Pokemon in non-small cell lung cancer and its clinical significance. Chin Med J (Engl) 2008, 121(5), 445–449.
   Web of Science ®Google Scholar
• Apostolopoulou, K.; Pateras, I.S.; Evangelou, K.; Tsantoulis, P.K.; Liontos, M.; Kittas, C.; Tiniakos, D.G.; Kotsinas, A.; Cordon-Cardo, C.; Gorgoulis, V.G. Gene amplification is a relatively frequent event leading to ZBTB7A (Pokemon) overexpression in non-small cell lung cancer. J Pathol 2007, 213(3), 294–302.
   PubMed Web of Science ®Google Scholar
• Maeda, T.; Hobbs, R.M.; Pandolfi, P.P. The transcription factor Pokemon: a new key player in cancer pathogenesis. Cancer Res 2005, 65(19), 8575–8578.
   PubMed Web of Science ®Google Scholar
• Ishibashi, M.; Nakayama, K.; Yeasmin, S.; Katagiri, A.; Iida, K.; Nakayama, N.; Fukumoto, M.; Miyazaki, K. A BTB/POZ gene, NAC-1, a tumor recurrence-associated gene, as a potential target for taxol resistance in ovarian cancer. Clin Cancer Res 2008, 14(10), 3149–3155.
   PubMed Web of Science ®Google Scholar
• Ishibashi, M.; Nakayama, K.; Yeasmin, S.; Katagiri, A.; Iida, K.; Nakayama, N.; Miyazaki, K. Expression of a BTB/POZ protein, NAC1, is essential for the proliferation of normal cyclic endometrial glandular cells and is up-regulated by estrogen. Clin Cancer Res 2009, 15(3), 804–811.
   PubMed Web of Science ®Google Scholar
• Nakayama, K.; Nakayama, N.; Davidson, B.; Sheu, J.J.; Jinawath, N.; Santillan, A.; Salani, R.; Bristow, R.E.; Morin, P.J.; Kurman, R.J.; Wang, T.L.; Shih, I.M. A BTB/POZ protein, NAC-1, is related to tumor recurrence and is essential for tumor growth and survival. Proc Natl Acad Sci USA 2006, 103(49), 18739–18744.
   PubMed Web of Science ®Google Scholar
• Astier, A.L.; Xu, R.; Svoboda, M.; Hinds, E.; Munoz, O.; de, B.R.; Crean, C.D.; Gabig, T.; Freedman, A.S. Temporal gene expression profile of human precursor B leukemia cells induced by adhesion receptor: identification of pathways regulating B-cell survival. Blood 2003, 101(3), 1118–1127.
   PubMed Web of Science ®Google Scholar
• Zhao, Z.H.; Wang, S.F.; Yu, L.; Wang, J.; Chang, H.; Yan, W.L.; Zhang, J.; Fu, K. Overexpression of Pokemon in non-small cell lung cancer and foreshowing tumor biological behavior as well as clinical results. Lung Cancer 2008, 62(1), 113–119.
   PubMed Web of Science ®Google Scholar
• Komori, H.; Enomoto, M.; Nakamura, M.; Iwanaga, R.; Ohtani, K. Distinct E2F-mediated transcriptional program regulates p14ARF gene expression. EMBO J 2005, 24(21), 3724–3736.
   PubMed Web of Science ®Google Scholar
• Godolphin, W.; Elwood, J.M.; Spinelli, J.J. Estrogen receptor quantitation and staging as complementary prognostic indicators in breast cancer: a study of 583 patients. Int J Cancer 1981, 28(6), 677–683.
   PubMed Web of Science ®Google Scholar
• Shek, L.L.; Godolphin, W. Survival with breast cancer: the importance of estrogen receptor quantity. Eur J Cancer Clin Oncol 1989, 25(2), 243–250.
   PubMedGoogle Scholar
• Polo, J.M.; Dell, O.T.; Ranuncolo, S.M.; Cerchietti, L.; Beck, D.; Da, S.G.; Prive, G.G.; Licht, J.D.; Melnick, A. Specific peptide interference reveals BCL6 transcriptional and oncogenic mechanisms in B-cell lymphoma cells. Nat Med 2004, 10(12), 1329–1335.
   PubMed Web of Science ®Google Scholar